tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
Advertisement

Karyopharm Therapeutics (KPTI) Revenue

Compare
1,202 Followers

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 37.93M in the quarter ending Jun 30, 2025, with 26.37%. This bring the company's revenue in the last twelve months to 137.27M, Increased -3.42%. In the fiscal year ending Dec 31, 2024, Karyopharm Therapeutics had annual revenue of 145.24M with -0.55% growth.
Revenue (ttm)
137.27M
Revenue Growth
-5.77%
P/S Ratio
0.39
Revenue/Employee
$520,563
Employees
279
Market Cap
$56.80M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
145.24M-796.00K+99.45%
Dec 31, 2023
146.03M-11.04M+92.97%
Dec 31, 2022
157.07M-52.74M+74.86%
Dec 31, 2021
209.82M101.73M+194.12%
Dec 31, 2020
108.08M67.19M+264.31%
Dec 31, 2019
40.89M10.56M+134.80%
Dec 31, 2018
30.34M28.73M+1,890.09%
Dec 31, 2017
1.60M1.45M+1,042.21%
Dec 31, 2016
154.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis